Buyout (LBO, MBO, MBI) • Life Science

Truffle Capital Acquires PK MED

On January 1, 2019, private equity firm Truffle Capital acquired life science company PK MED

Acquisition Context
  • This is Truffle Capital’s 9th transaction in the Life Science sector.
  • This is Truffle Capital’s 31st transaction in France.

Explore All 460 Buyout (LBO, MBO, MBI) Life Science Deals - Search the Database Free


M&A Deal Summary

Date January 1, 2019
Target PK MED
Sector Life Science
Buyer(s) Truffle Capital
Deal Type Buyout (LBO, MBO, MBI)

Target Company

PK MED

Paris, France
PK MED offers therapeutic solutions for local pain treatments in inflammatory joint diseases and tissue regeneration, using 3D implants for example. PK MED is based in Paris, France.
Explore More Deals

Browse All 215,130 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Buyer Overview 1

Buyer

Truffle Capital

Paris, France

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 2001
PE ASSETS 700M EUR
Size Middle-Market
Type Sector Focused
DESCRIPTION

Truffle Capital is a French private equity firm focused on majority investments in life science and information technology companies. Within IT, Truffle seeks businesses dealing in mobile content and connectivity, internet, technical software, IT security, and VOIP. Within the life science sector, the Firm looks at opportunities in therapeutic drugs and vaccines, medical devices, as well as other breakthrough technologies. Truffle Capital was formed in 2001 and is based in Paris.


Deal Context for Buyer #
Overall 43 of 45
Sector: Life Science 9 of 9
Type: Buyout (LBO, MBO, MBI) 17 of 18
Country: France 31 of 33
Year: 2019 2 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-01-01 BariaTek

Paris, France

BariaTek is dedicated to the development of innovative medical devices intended to combat obesity and diabetes, two pandemics affecting more than a billion patients around the world. These minimally invasive devices are implanted in a few minutes by endoscopy and reproduce the effects of obesity surgery (or bariatric surgery). BariaTek is based in Paris, France.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2019-12-23 SmartPush

Marseille, France

SmartPush analyzes banking data and enriches account statements using artificial intelligence to categorize transactional data. SmartPush was founded in 2016 and is based in Marseille, France.

Buy -